Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients

Morell-Hita, Jose Luis; Rigual-Bobillo, Juan A; Macía-Villa, Cristina C.
Reumatol. clín. (Barc.) ; 18(10): 625-626, dic. 2022. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-211902

Documentos relacionados

  1. Characterization of a mouse-adapted strain of bat severe acute respiratory syndrome-related coronavirus.
  2. Management of post-mortem examination in SARS-CoV-19 infections.
  3. [Living with an ongoing crisis - insights from the coronavirus - SARS-CoV].
  4. Coronavirus: time to re-imagine academic publishing.
  5. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.
  6. Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series.
  7. Comment on "Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series."Author reply.
  8. Coronavirus outbreak: what's next?
  9. Comment on "Humoral and cellular response to a third booster dose SARS-CoV- 2 vaccination in patients with autoimmune disease: a case series".
  10. SARS-CoV-2: Combating Coronavirus Emergence.